Aspirin increases the risk of major bleeding in large study of Italian patients. June 5, 2012— -- For years, the advice for preventing heart disease has been simple: take an aspirin every day; it ...
A meta-analysis of individual patient data has thrown light on the benefits of aspirin for secondary prevention in patients with ischaemic stroke. The findings, published in The Lancet, show that the ...
Aspirin does not protect women against heart attacks in the same way it does men, but the venerable painkiller does cut women's chances of suffering a stroke, researchers reported yesterday. A ...
HealthDay News — Regular aspirin use significantly reduced risk of cancer, metastasis and cancer mortality, findings from the largest-ever analyses exploring the drug’s effects on cancer indicate.
A recent study by the Annenberg Public Policy Center found that nearly half of United States adults incorrectly believe the benefits of daily aspirin use outweigh the potential risks. Credit: Weining ...
Aspirin reduces cardiovascular risk with a distinct advantage for each gender, protecting men against heart attacks and women against strokes, a study found. Researchers reported the results of the ...
Researchers found the risk of brain bleeding while using low-dose aspirin outweighed any potential benefit against stroke for relatively healthy older adults -- that is, those with no history of heart ...
For years, doctors recommended that older adults at a higher risk for heart attack or stroke take a low-dose aspirin once a day to lower their risk. Aspirin helps prevent blood clots from forming, ...
Daily low-dose aspirin is no longer recommended for heart attack prevention for people 60 and over, but many still take it despite risks, a new survey finds. (Getty Images) Many older adults are ...
Daily aspirin therapy may lower your risk of heart attack, but daily aspirin therapy isn’t for everyone. Is it right for you? If you’ve had a heart attack or stroke, your doctor will likely recommend ...
New research highlighted how aspirin is unnecessary in antithrombotic regimens for patients with advanced heart failure and fully magnetically levitated left ventricular assist devices (LVADs). Among ...